Marex Group Limited MRX
68.19 USD -0.19 (-0.28%)
Nov 4, 2026, 10:09 AM EST
67.28 Day range 69.60
30.30 52-week range 79.11
- YTD
- +77.76%
- 1 year
- +122.04%
Analyst view
Consensus: buy
Buy
Price target (mean) 81.88 +20.1% upside
Now 68.19
- Target (low)
- 36.00
- Target (mean)
- 81.88
- Target (high)
- 100.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy3
- Buy5
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.54 | 1.48 – 1.61 | 0.96 | +60.0% | 681.51M | +40.6% | 8 |
| Next quarter | 1.55 | 1.50 – 1.64 | 1.13 | +37.5% | 697.77M | +22.0% | 7 |
| Current year | 6.18 | 5.96 – 6.37 | 3.99 | +55.0% | 2.77B | +36.6% | 8 |
| Next year | 7.01 | 6.62 – 7.31 | 6.18 | +13.3% | 3.03B | +9.7% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | William Blair | Initiated | — | Outperform |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 2, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 13, 2026 | UBS | Maintained | Buy | Buy |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 13, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 20, 2026 | Jefferies | Maintained | Buy | Buy |
| Jul 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 10, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 8, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 2, 2026 | UBS | Maintained | Buy | Buy |
| Mar 27, 2026 | TD Cowen | Maintained | Buy | Buy |
| Mar 27, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 4, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 14, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jan 14, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Dec 12, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 7, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 8, 2025 | Barclays | Maintained | Overweight | Overweight |
| Aug 14, 2025 | Barclays | Maintained | Overweight | Overweight |
| Jun 9, 2025 | Barclays | Maintained | Overweight | Overweight |
| May 16, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| May 16, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Apr 7, 2025 | Barclays | Maintained | Overweight | Overweight |
| Apr 3, 2025 | Goldman Sachs | Maintained | Buy | Buy |
